Health Catalyst, Inc. (HCAT)

Market Cap	431.41M
Revenue (ttm)	302.06M
Net Income (ttm)	-79.14M
Shares Out	60.85M
EPS (ttm)	-1.34
PE Ratio	n/a
Forward PE	21.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	870,874
Open	6.84
Previous Close	6.97
Day's Range	6.75 - 7.25
52-Week Range	5.42 - 11.41
Beta	1.33
Analysts	Buy
Price Target	11.75 (+65.73%)
Earnings Date	Nov 6, 2024

About HCAT

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and ...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jul 25, 2019
• Employees: 1,300
• Stock Exchange: NASDAQ
• Ticker Symbol: HCAT
• Website: https://www.healthcatalyst.com

Financial Performance

In 2023, Health Catalyst's revenue was $295.94 million, an increase of 7.13% compared to the previous year's $276.24 million. Losses were -$118.15 million, -14.01% less than in 2022.

Analyst Forecast

According to 11 analysts, the average rating for HCAT stock is "Buy." The 12-month stock price forecast is $11.75, which is an increase of 65.73% from the latest price.

Price Target

$11.75

(65.73% upside)

Analyst Consensus: Buy